Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target
Abstract Diffuse large B-cell lymphoma (DLBC) is the most common subtype of non-Hodgkin lymphoma, characterized by its aggressive nature and poor prognosis in advanced stages. Despite advances in treatment, the molecular mechanisms driving DLBC progression remain incompletely understood, necessitati...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Hereditas |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41065-025-00411-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850172723661111296 |
|---|---|
| author | Junaid Abid Mahmood Basil A. Al-Rawi Ahmad Mahmood An Li Tiemin Jiang |
| author_facet | Junaid Abid Mahmood Basil A. Al-Rawi Ahmad Mahmood An Li Tiemin Jiang |
| author_sort | Junaid Abid |
| collection | DOAJ |
| description | Abstract Diffuse large B-cell lymphoma (DLBC) is the most common subtype of non-Hodgkin lymphoma, characterized by its aggressive nature and poor prognosis in advanced stages. Despite advances in treatment, the molecular mechanisms driving DLBC progression remain incompletely understood, necessitating the identification of novel biomarkers for diagnosis and prognosis. In this study, we analyzed two publicly available datasets (GSE32018 and GSE56315) from the Gene Expression Omnibus database (GEO) to identify overlapping differentially expressed genes (DEGs). Later on, a comprehensive in silico and in vitro methodology was adopted to decipher the role of identify DEGs in DLBC. DEGs analysis of GSE32018 and GSE56315 datasets identified five overlapping gene: SP3, CSNK1A1, STYX, SIRT5, and MGEA5. Expression validation using the GEPIA2 database confirmed the upregulation of SP3, CSNK1A1, STYX, and SIRT5, and the downregulation of MGEA5 in DLBC tissues compared to normal controls. Furthermore, mutational analysis revealed that CSNK1A1 was the only gene among these DEGs to exhibit mutations, with a 2.7% mutation frequency in DLBC patients. Methylation analysis highlighted a negative correlation between DEGs methylation levels and mRNA expression, while survival analysis identified high STYX expression as significantly associated with poorer overall survival in DLBC patients. Functional assays demonstrated that STYX knockdown in U2932 cells led to reduced cell proliferation, colony formation, and enhanced wound healing, indicating STYX’s pivotal role in DLBC cell survival and migration. Additionally, gene enrichment analysis revealed the involvement of these DEGs in key biological processes, including intracellular trafficking and myeloid progenitor cell differentiation. These findings emphasize the potential of SP3, CSNK1A1, STYX, SIRT5, and MGEA5 as biomarkers and therapeutic targets in DLBC, particularly highlighting STYX as a promising prognostic marker and potential target for therapeutic intervention. |
| format | Article |
| id | doaj-art-7e34a650f45f42e1a8a804f0029f0245 |
| institution | OA Journals |
| issn | 1601-5223 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | BMC |
| record_format | Article |
| series | Hereditas |
| spelling | doaj-art-7e34a650f45f42e1a8a804f0029f02452025-08-20T02:20:01ZengBMCHereditas1601-52232025-03-01162111710.1186/s41065-025-00411-wIdentification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic targetJunaid Abid0Mahmood Basil A. Al-Rawi1Ahmad Mahmood2An Li3Tiemin Jiang4State Key Laboratory of Food Nutrition and Safety, College of Biotechnology, Tianjin University of Science and TechnologyDepartment of Optometry, College of Applied Medical Sciences, King Saud UniversityDepartment of Hepatobiliary & Hydatid Diseases, Digestive & Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityDepartment of Hepatobiliary & Hydatid Diseases, Digestive & Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityDepartment of Hepatobiliary & Hydatid Diseases, Digestive & Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityAbstract Diffuse large B-cell lymphoma (DLBC) is the most common subtype of non-Hodgkin lymphoma, characterized by its aggressive nature and poor prognosis in advanced stages. Despite advances in treatment, the molecular mechanisms driving DLBC progression remain incompletely understood, necessitating the identification of novel biomarkers for diagnosis and prognosis. In this study, we analyzed two publicly available datasets (GSE32018 and GSE56315) from the Gene Expression Omnibus database (GEO) to identify overlapping differentially expressed genes (DEGs). Later on, a comprehensive in silico and in vitro methodology was adopted to decipher the role of identify DEGs in DLBC. DEGs analysis of GSE32018 and GSE56315 datasets identified five overlapping gene: SP3, CSNK1A1, STYX, SIRT5, and MGEA5. Expression validation using the GEPIA2 database confirmed the upregulation of SP3, CSNK1A1, STYX, and SIRT5, and the downregulation of MGEA5 in DLBC tissues compared to normal controls. Furthermore, mutational analysis revealed that CSNK1A1 was the only gene among these DEGs to exhibit mutations, with a 2.7% mutation frequency in DLBC patients. Methylation analysis highlighted a negative correlation between DEGs methylation levels and mRNA expression, while survival analysis identified high STYX expression as significantly associated with poorer overall survival in DLBC patients. Functional assays demonstrated that STYX knockdown in U2932 cells led to reduced cell proliferation, colony formation, and enhanced wound healing, indicating STYX’s pivotal role in DLBC cell survival and migration. Additionally, gene enrichment analysis revealed the involvement of these DEGs in key biological processes, including intracellular trafficking and myeloid progenitor cell differentiation. These findings emphasize the potential of SP3, CSNK1A1, STYX, SIRT5, and MGEA5 as biomarkers and therapeutic targets in DLBC, particularly highlighting STYX as a promising prognostic marker and potential target for therapeutic intervention.https://doi.org/10.1186/s41065-025-00411-wDLBCDiagnosisPrognosis: TreatmentTherapeutic target |
| spellingShingle | Junaid Abid Mahmood Basil A. Al-Rawi Ahmad Mahmood An Li Tiemin Jiang Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target Hereditas DLBC Diagnosis Prognosis: Treatment Therapeutic target |
| title | Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target |
| title_full | Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target |
| title_fullStr | Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target |
| title_full_unstemmed | Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target |
| title_short | Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target |
| title_sort | identification and functional characterization of key biomarkers in diffuse large b cell lymphoma emphasis on styx as a prognostic marker and therapeutic target |
| topic | DLBC Diagnosis Prognosis: Treatment Therapeutic target |
| url | https://doi.org/10.1186/s41065-025-00411-w |
| work_keys_str_mv | AT junaidabid identificationandfunctionalcharacterizationofkeybiomarkersindiffuselargebcelllymphomaemphasisonstyxasaprognosticmarkerandtherapeutictarget AT mahmoodbasilaalrawi identificationandfunctionalcharacterizationofkeybiomarkersindiffuselargebcelllymphomaemphasisonstyxasaprognosticmarkerandtherapeutictarget AT ahmadmahmood identificationandfunctionalcharacterizationofkeybiomarkersindiffuselargebcelllymphomaemphasisonstyxasaprognosticmarkerandtherapeutictarget AT anli identificationandfunctionalcharacterizationofkeybiomarkersindiffuselargebcelllymphomaemphasisonstyxasaprognosticmarkerandtherapeutictarget AT tieminjiang identificationandfunctionalcharacterizationofkeybiomarkersindiffuselargebcelllymphomaemphasisonstyxasaprognosticmarkerandtherapeutictarget |